Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yogendra Kumar Gupta

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 31, 2016
Molecular mechanisms underlying attenuation of cisplatin-induced acute kidney injury by epicatechin gallateSalma Malik, Kapil Suchal, Jagriti Bhatia, et al.
JAMA Oncology|April 7, 2017
Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical TrialRaja Pramanik, Sandeep Agarwala, Yogendra Kumar Gupta, et al.
Journal of Ethnopharmacology|January 11, 2021
Pharmacodynamic and pharmacokinetic interactions of hydroalcoholic leaf extract of Centella asiatica with valproate and phenytoin in experimental models of epilepsy in ratsRitesh Kumar, Renu Arora, Sudhir Chandra Sarangi, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|September 6, 2019
Issues, challenges, and the way forward in conducting clinical trials among neonates: investigators' perspectiveSindhu Sivanandan, Kajal Jain, Nishad Plakkal, et al.
Neoplasma|January 2, 2023
Evaluation of serum glucose-regulated protein 78 (GRP78) as a biomarker of treatment response to bortezomib-based induction regimen in multiple myeloma: A cross-sectional pilot studySuganthi Sekaran Ramachandran, Pooja Gupta, Lalit Kumar, et al.
Toxicology and Applied Pharmacology|June 3, 2008
Correlation of phthalate exposures with semen qualityNiraj Pant, Manju Shukla, Devendra Kumar Patel, et al.
Indian Journal of Pharmacology|May 5, 2025
Digital platform for prescription analytics and antibiotic surveillance in an outpatient department setupSaumya Kankanala, Krishna Prakash Joshi, Mohammad Nezamuddin Khan, et al.
Leukemia & Lymphoma|April 4, 2017
Do polymorphisms in MDR1 and CYP3A5 genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinib therapy?Natarajan Harivenkatesh, Lalit Kumar, Sameer Bakhshi, et al.
Leukemia & Lymphoma|August 21, 2018
Imatinib trough levels: a potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemiaHarivenkatesh Natarajan, Lalit Kumar, Sameer Bakhshi, et al.
Pharmacological Research|March 24, 2017
Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemiaNatarajan Harivenkatesh, Lalit Kumar, Sameer Bakhshi, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 31, 2016
Molecular mechanisms underlying attenuation of cisplatin-induced acute kidney injury by epicatechin gallateSalma Malik, Kapil Suchal, Jagriti Bhatia, et al.
JAMA Oncology|April 7, 2017
Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical TrialRaja Pramanik, Sandeep Agarwala, Yogendra Kumar Gupta, et al.
Journal of Ethnopharmacology|January 11, 2021
Pharmacodynamic and pharmacokinetic interactions of hydroalcoholic leaf extract of Centella asiatica with valproate and phenytoin in experimental models of epilepsy in ratsRitesh Kumar, Renu Arora, Sudhir Chandra Sarangi, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|September 6, 2019
Issues, challenges, and the way forward in conducting clinical trials among neonates: investigators' perspectiveSindhu Sivanandan, Kajal Jain, Nishad Plakkal, et al.
Neoplasma|January 2, 2023
Evaluation of serum glucose-regulated protein 78 (GRP78) as a biomarker of treatment response to bortezomib-based induction regimen in multiple myeloma: A cross-sectional pilot studySuganthi Sekaran Ramachandran, Pooja Gupta, Lalit Kumar, et al.
Toxicology and Applied Pharmacology|June 3, 2008
Correlation of phthalate exposures with semen qualityNiraj Pant, Manju Shukla, Devendra Kumar Patel, et al.
Indian Journal of Pharmacology|May 5, 2025
Digital platform for prescription analytics and antibiotic surveillance in an outpatient department setupSaumya Kankanala, Krishna Prakash Joshi, Mohammad Nezamuddin Khan, et al.
Leukemia & Lymphoma|April 4, 2017
Do polymorphisms in MDR1 and CYP3A5 genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinib therapy?Natarajan Harivenkatesh, Lalit Kumar, Sameer Bakhshi, et al.
Leukemia & Lymphoma|August 21, 2018
Imatinib trough levels: a potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemiaHarivenkatesh Natarajan, Lalit Kumar, Sameer Bakhshi, et al.
Pharmacological Research|March 24, 2017
Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemiaNatarajan Harivenkatesh, Lalit Kumar, Sameer Bakhshi, et al.
Pageof 12